Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
Clinical Trials Summit 2026
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
Clinical Trials Summit 2026
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
Clinical Trials Summit 2026
Search here...
Search
Tag:
Cipla respiratory drugs
Cipla Receives U.S. FDA Approval for Generic Advair Diskus®️
Breaking News
Dose Daily News Bureau
-
July 30, 2026
Cipla Limited and its wholly owned subsidiary, Cipla USA Inc., have received approval from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug Application...
I want in
I've read and accept the
Privacy Policy
.
AstraZeneca reports Mixed Phase III Results for Ultomiris in Rare Post-Transplant Blood Disorder
Dose Daily News Bureau
-
July 30, 2026
Cipla Receives U.S. FDA Approval for Generic Advair Diskus®️
Breaking News
Government of Andhra Pradesh Partners to Launch AI and Genomic-Powered 360-Degree Oncology Care Model
Breaking News
Cognizant Expands Strategic Partnership with Novartis to Transform Global IT Operations using Agentic AI
Breaking News
Seven Clinical Trial Ethics Panels Lose CDSCO Registration in Compliance Crackdown
Breaking News
From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story
Breaking News
×